Public live Zoom webinars on "Introduction to Adaptive Trial Designs using FACTS" are scheduled for October and November.

The blog by Kert Viele discusses the tradeoffs of using external or synthetic data in clinical trials, highlighting how aggressive use can save patient resources but risks scientific robustness, and emphasizes the importance of understanding the agreement between synthetic and actual trial data to optimize inferential performance while minimizing patient enrollment.

The new JAMA Guide to Statistics and Methods by Dr. Barbara Wendelberger and Dr. Roger Lewis examines the concept of futility in clinical trials.

Visit the Berry Consultants booth to meet our team and experience demos of our latest software products: FACTS 7, ADDPLAN, and QUOTES.

The Berry Consultants team will present sessions on May 22 at 2:45 PM EST and May 23 at 4:15 PM EST.

On May 12, Dr. Amy Crawford and Dr. Joe Marion from Berry Consultants will present at the FDA/AdvaMed Conference.